当前位置：药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目更新到2026-3-31)
药品名称： 商品名称： 药品NDC： 报告期内： -格式:2020-5-3
NDC包装id： 市场分类： 活性成分： 持证企业：
 美国NDC复合药物数据库文件4843条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
031010 BETAMETHASONE DIPROPIONATE 0.05% / MINOXIDIL 5% Solution
HUMAN COMPOUNDED DRUG
72934-4343
SKNV
2024-2
BETAMETHASONE DIPROPIONATE; MINOXIDIL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.05 g/100 mL; 5 g/100 mL
72934-4343-8
141016 HYDROCORTISONE 0.5% / HYDROQUINONE 4% / TRETINOIN 0.025%
HUMAN COMPOUNDED DRUG
72934-6375
SKNV
2024-2
TRETINOIN; HYDROCORTISONE; HYDROQUINONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.025 g/100 mL; .5 g/100 mL; 4 g/100 mL
72934-6375-2
221025 CANTHARIDIN 1% / PODOPHYLLUM RESIN 5% / SALICYLIC ACID 30%
HUMAN COMPOUNDED DRUG
72934-9410
SKNV
2024-2
CANTHARIDIN; PODOPHYLLUM RESIN; SALICYLIC ACID
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 g/100 mL; 5 g/100 mL; 30 g/100 mL
72934-9410-1
351032 NIACINAMIDE 4% / SULFACETAMIDE SODIUM MONOHYDRATE 10%
HUMAN COMPOUNDED DRUG
72934-2421
SKNV
2024-2
SULFACETAMIDE SODIUM; NIACINAMIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 g/100 mL; 4 g/100 mL
72934-2421-2
201034 BENZOCAINE 20% / LIDOCAINE 8% / TETRACAINE 4%
HUMAN COMPOUNDED DRUG
72934-5405
SKNV
2024-1
LIDOCAINE; TETRACAINE; BENZOCAINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
8 g/100 mL; 4 g/100 mL; 20 g/100 mL
72934-5405-4
201026 LIDOCAINE 15% / PHENYLEPHRINE HCL 0.25% / PRILOCAINE 5%
HUMAN COMPOUNDED DRUG
72934-5403
SKNV
2024-1
LIDOCAINE; PRILOCAINE; PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
15 g/100 mL; 5 g/100 mL; .25 g/100 mL
72934-5403-4
141069 HYDROQUINONE 8%//TRETINOIN 0.025%
HUMAN COMPOUNDED DRUG
72934-6392
SKNV
2024-1
HYDROQUINONE; TRETINOIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
8 g/100 mL; .025 g/100 mL
72934-6392-2
011527 BENZOYL PEROXIDE 5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / SPIRONOLACTONE 2% / TRETINOIN 0.025% Gel
HUMAN COMPOUNDED DRUG
72934-1333
SKNV
2024-1
SPIRONOLACTONE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE; NIACINAMIDE; TRETINOIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 g/100 mL; 5 g/100 mL; 1 g/100 mL; 2 g/100 mL; .025 g/100 mL
72934-1333-2
011518 BENZOYL PEROXIDE 5% / CLINDAMYCIN 1% / NIACINAMIDE 4%
HUMAN COMPOUNDED DRUG
72934-1327
SKNV
2024-1
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE; NIACINAMIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 g/100 mL; 1 g/100 mL; 4 g/100 mL
72934-1327-2
011531 ADAPALENE 0.3% / BENZOYL PEROXIDE 2.5% / NIACINAMIDE 4% Gel
HUMAN COMPOUNDED DRUG
72934-1335
SKNV
2024-1
BENZOYL PEROXIDE; ADAPALENE; NIACINAMIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2.5 g/100 mL; .3 g/100 mL; 4 g/100 mL
72934-1335-2
TESTOSTERONE/ANASTRAZOLE 75 MG/4 MG
HUMAN COMPOUNDED DRUG
73271-0754
Right Value Drug Stores llc dba Carie Boyd Pharmaceuticals
2024-2
ANASTROZOLE; TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4 mg; 75 mg
73271-0754-1
ESTRADIOL 20 PEL
HUMAN COMPOUNDED DRUG
73271-0020
Right Value Drug Stores llc dba Carie Boyd Pharmaceuticals
2024-2
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg
73271-0020-1
ESTRADIOL 22 PEL
HUMAN COMPOUNDED DRUG
73271-0022
Right Value Drug Stores llc dba Carie Boyd Pharmaceuticals
2024-2
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
22 mg
73271-0022-1
TESTOSTERONE/ANASTROZOLE 100 MG/4 MG
HUMAN COMPOUNDED DRUG
73271-1004
Right Value Drug Stores llc dba Carie Boyd Pharmaceuticals
2024-2
ANASTROZOLE; 1-TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4 mg; 100 mg
73271-1004-1
ESTRADIOL 6 PEL
HUMAN COMPOUNDED DRUG
73271-0006
Right Value Drug Stores llc dba Carie Boyd Pharmaceuticals
2024-2
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
6 mg
73271-0006-1
ESTRADIOL 18 PEL
HUMAN COMPOUNDED DRUG
73271-0018
Right Value Drug Stores llc dba Carie Boyd Pharmaceuticals
2024-2
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
18 mg
73271-0018-1
ESTRADIOL 50 PEL
HUMAN COMPOUNDED DRUG
73271-0050
Right Value Drug Stores llc dba Carie Boyd Pharmaceuticals
2024-2
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg
73271-0050-1
ESTRADIOL 10 PEL
HUMAN COMPOUNDED DRUG
73271-0010
Right Value Drug Stores llc dba Carie Boyd Pharmaceuticals
2024-2
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg
73271-0010-1
TESTOSTERONE SA2 87.5MG
HUMAN COMPOUNDED DRUG
70713-007
Wells Pharmacy, Inc
2024-2
TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
87.5 mg
70713-007-01
TESTOSTERONE SA2 200MG
HUMAN COMPOUNDED DRUG
70713-001
Wells Pharmacy, Inc
2024-2
TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
200 mg
70713-001-01
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3